{"id":30769,"date":"2026-03-02T14:20:12","date_gmt":"2026-03-02T14:20:12","guid":{"rendered":"https:\/\/www.europesays.com\/dk\/30769\/"},"modified":"2026-03-02T14:20:12","modified_gmt":"2026-03-02T14:20:12","slug":"this-novo-nordisk-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-monday-aardvark-therapeutics-nasdaqaard-fiverr-intl-nysefvrr","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/dk\/30769\/","title":{"rendered":"This Novo Nordisk Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday &#8211; Aardvark Therapeutics (NASDAQ:AARD), Fiverr Intl (NYSE:FVRR)"},"content":{"rendered":"<p class=\"block core-block\">Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href=\"https:\/\/www.benzinga.com\/analyst-stock-ratings\" target=\"_blank\" rel=\"nofollow noopener\">analyst ratings page<\/a>.<\/p>\n<p class=\"block core-block\">Considering buying NVO stock? Here\u2019s what analysts think: <\/p>\n<p class=\"block core-block\">Photo via Shutterstock<\/p>\n<p><a class=\"text-sm my-4\" href=\"https:\/\/www.benzinga.com\/apis?utm_source=benzinga.com&amp;utm_campaign=article-bottom\" rel=\"noreferrer nofollow noopener\" target=\"_blank\">Market News and Data brought to you by Benzinga APIs<\/a><\/p>\n<p class=\"copyright\">\u00a9 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.<\/p>\n<p class=\"block core-block\">To add Benzinga News as your preferred source on Google, <a href=\"https:\/\/google.com\/preferences\/source?q=https%3A%2F%2Fwww.benzinga.com\" rel=\"noreferrer nofollow noopener\" target=\"_blank\">click here<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst&hellip;\n","protected":false},"author":2,"featured_media":30770,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[271],"tags":[18403,18402,2088,14810,2093,2084,272,352,18404,18405,2096,18406],"class_list":{"0":"post-30769","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-novo-nordisk","8":"tag-category-analyst-ratings","9":"tag-category-downgrades","10":"tag-category-news","11":"tag-category-pre-market-outlook","12":"tag-category-trading-ideas","13":"tag-cms-wordpress","14":"tag-novo-nordisk","15":"tag-pageisbzpro-bz","16":"tag-symbol-aard","17":"tag-symbol-fvrr","18":"tag-symbol-nvo","19":"tag-tag-top-downgrades"},"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/30769","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/comments?post=30769"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/30769\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media\/30770"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media?parent=30769"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/categories?post=30769"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/tags?post=30769"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}